These results suggest that though SOX11 is typically more highly expressed in basal-like and HER2-positive breast cancer, it likely functions in other breast cancer subtypes to promote the growth of aggressive, poor-prognosis tumors. The gene discussed is SOX11; the disease is breast cancer.